世界の医療用相互運用性ソリューション市場(~2026年):種類別(EHR相互運用性、医療情報交換、企業)、相互運用性レベル別(基礎的、構造的、意味論的)、エンドユーザー別(病院、薬局、クリニック、支払者)

【英語タイトル】Healthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantic), End User (Hospitals, Pharmacies, Clinics, Payers) - Global Forecast to 2026

MarketsandMarketsが出版した調査資料(HIT6989)・商品コード:HIT6989
・発行会社(調査会社):MarketsandMarkets
・発行日:2022年1月25日
・ページ数:228
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

マーケッツアンドマーケッツ社は、世界の医療用相互運用性ソリューション市場規模が、2021年29億ドルから2026年57億ドルまで年平均13.9%成長すると予測しています。本調査資料では、医療用相互運用性ソリューションの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業動向、種類別(ソフトウェア、サービス)分析、相互運用性レベル別(基礎的、構造的、意味論的)分析、エンドユーザー別(医療提供者、医療費支払者、薬局)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業動向
・世界の医療用相互運用性ソリューション市場規模:種類別(ソフトウェア、サービス)
・世界の医療用相互運用性ソリューション市場規模:相互運用性レベル別(基礎的、構造的、意味論的)
・世界の医療用相互運用性ソリューション市場規模:エンドユーザー別(医療提供者、医療費支払者、薬局)
・世界の医療用相互運用性ソリューション市場規模:地域別
・競争状況
・企業情報

“The global healthcare interoperability solutions market is projected to reach USD 5.7 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 13.9% during the forecast period.”
Growth in this market is driven by the growing need to curtail healthcare costs, government initiatives to enhance patient care & safety, government funding for healthcare interoperability, and the rapid adoption of EHR & other healthcare IT solutions. However, the lack of true interoperability solutions, lack of standards, and the use of outdated legacy systems are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period.

“Serviceswas the largest and fastest-growing segment in thetype of healthcare interoperability solutions marketin 2020”
Services accounted for the largest share of healthcare interoperability solutions market in 2020. The large share of this segment can be attributed to the recurring cost of services such as software upgrades/updates and maintenance.

“Healthcare Providersis the largest end user segment inthe healthcare interoperability solutionsmarket in 2020”
Based on the end user, the healthcare interoperability solutionsmarket is into veterinary clinics, veterinary hospitals & academic institutes, and other end users. In 2020, the veterinary clinics segment accounted for the largest share of the global healthcare interoperability solutions market. The large share of this segment can be attributed to factors such as the increasing patient volume, the need to curtail the rising healthcare costs, and government mandates.

“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as increasing government initiatives for eHealth, rising medical tourism, growing demand for quality healthcare, and the growing need for the implementation and integration of medical devices and HCIT solutions to provide cost-effective and quality care to patients.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1:55%, Tier 2: 30%, and Tier 3: 15%
• By Designation – C-level: 50%, Director-level: 35%,and Others: 15%
• By Region – North America: 48%,Europe: 32%,AsiaPacific: 15%,and Rest of the World: 5%.

Key players in the Healthcare interoperability solutions Market
The key players operating in the healthcare interoperability solutions market includeCerner Corporation (US), Epic Systems Corporation (US), Infor, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), IBM Watson Health (US), Lyniate (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), and Medical Information Technology, Inc. (US).

Research Coverage:
The report analyzesthe healthcare interoperability solutionsmarket and aims at estimating the market size and future growth potential of various market segments, based ontype, level of interoperability, end user, and region. The report also providesa competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would helpthem garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies tostrengthen their positions in the market.

This report provides insights on:
 Market Penetration: Comprehensive information on the product portfolios ofthe top players in the Healthcare interoperability solutions Market. The report analyzes this marketbytype, level of interoperability, end user, and region.
 Market Development: Comprehensive information on the lucrative emerging markets,type, level of interoperability, end user, and region.
 Market Diversification: Exhaustive information about theproduct portfolios, growing geographies, recent developments, and investments in thehealthcare interoperability solutionsmarket
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of theleading players in thehealthcare interoperability solutions market

❖ レポートの目次 ❖

1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 30
1.2.2 MARKETS COVERED 30
1.2.3 YEARS CONSIDERED FOR THE STUDY 31
1.3 CURRENCY 31
1.4 LIMITATIONS 31
1.5 STAKEHOLDERS 32
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH APPROACH 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY RESEARCH 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 35
2.1.2.1 Primary sources 35
2.1.2.2 Key data from primary sources 36
2.1.2.3 Insights from primary experts 37
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 38
FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 38
FIGURE 4 CAGR PROJECTIONS: OVERALL HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 40
2.2.1 TOP-DOWN APPROACH 40
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 5 DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET RANKING ANALYSIS 43
2.5 ASSUMPTIONS FOR THE STUDY 43
2.6 LIMITATIONS 44
2.6.1 METHODOLOGY-RELATED LIMITATIONS 44
2.6.2 SCOPE-RELATED LIMITATIONS 44
2.7 RISK ASSESSMENT 44
TABLE 1 RISK ASSESSMENT: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 44

3 EXECUTIVE SUMMARY 45
FIGURE 6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 45
FIGURE 7 HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 46
FIGURE 8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2021 VS. 2026 (USD MILLION) 47
FIGURE 9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2021 VS. 2026 (USD MILLION) 48
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 49
4 PREMIUM INSIGHTS 50
4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW 50
FIGURE 11 GOVERNMENT INITIATIVES TO ENHANCE PATIENT CARE AND SAFETY—A KEY FACTOR DRIVING MARKET GROWTH 50
4.2 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE & COUNTRY (2020) 51
FIGURE 12 SERVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN 2020 51
4.3 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
FIGURE 13 APAC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 52
4.4 REGIONAL MIX: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET (2021–2026) 53
FIGURE 14 NORTH AMERICA TO DOMINATE THE MARKET DURING THE FORECAST PERIOD (2021–2026) 53
4.5 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2021 VS. 2026 53
FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH BETWEEN
2021 AND 2026 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 16 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Growing need to curtail healthcare costs 55
5.2.1.2 Government initiatives to enhance patient care and safety 55
5.2.1.3 Government funding for healthcare interoperability 57
5.2.1.4 Rapid adoption of electronic health records and other healthcare IT solutions 58
5.2.2 RESTRAINTS 58
5.2.2.1 Lack of true interoperability solutions 58
5.2.2.2 Lack of standards 59
5.2.2.3 Use of outdated legacy systems 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Emerging markets for healthcare interoperability solutions in developing countries 61
5.2.4 CHALLENGES 61
5.2.4.1 Increasing complexity with lack of consistent data 61
5.2.4.2 Shortage of skilled healthcare IT professionals 62
5.2.4.3 Data privacy concerns 62
5.3 PATENT ANALYSIS 63
5.3.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE INTEROPERABILITY SOLUTIONS 63
FIGURE 18 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 64
5.3.2 JURISDICTION AND TOP APPLICANT ANALYSIS 64
FIGURE 19 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE INTEROPERABILITY SOLUTION PATENTS (JANUARY 2011 TO DECEMBER 2021) 65
FIGURE 20 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE INTEROPERABILITY SOLUTION PATENTS (JANUARY 2011 TO DECEMBER 2021) 65
5.4 ECOSYSTEM ANALYSIS 66
FIGURE 21 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 66
5.5 TECHNOLOGY ANALYSIS 66
5.5.1 MACHINE LEARNING 66
5.5.2 SMART ON FHIR 67
5.5.3 AI PLATFORMS 67
5.6 ADJACENT MARKET ANALYSIS 67
5.6.1 HEALTHCARE IT INTEGRATION MARKET 67
FIGURE 22 HEALTHCARE IT INTEGRATION MARKET OVERVIEW 68
5.6.2 HEALTHCARE IT MARKET 68
FIGURE 23 HEALTHCARE IT MARKET OVERVIEW 68
6 INDUSTRY INSIGHTS 69
6.1 INTRODUCTION 69
6.2 INDUSTRY TRENDS 69
6.2.1 FAST HEALTHCARE INTEROPERABILITY RESOURCES 69
6.2.2 SMART ON FHIR 70
6.2.3 GROWING NEED FOR SEMANTIC INTEROPERABILITY 71
6.2.4 INCREASING ADOPTION OF APPLICATION PROGRAMMING INTERFACE 71
6.3 INTEROPERABILITY STANDARDS 72
TABLE 2 KEY STANDARDS FOR INTEROPERABILITY IN THE DIGITAL HEALTH SPECTRUM 72
6.4 IMPACT OF COVID-19 ON THE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 75
6.5 REGULATORY ANALYSIS 76
TABLE 3 KEY REGULATIONS & STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY 77
7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE 79
7.1 INTRODUCTION 80
TABLE 4 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 80
7.2 SOFTWARE SOLUTIONS 80
TABLE 5 HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET,
BY TYPE, 2019–2026(USD MILLION) 81
TABLE 6 HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 82
7.2.1 EHR INTEROPERABILITY SOLUTIONS 82
7.2.1.1 Large installation base of EHR systems and the need to make them interoperable—key factors driving market growth 82
TABLE 7 EHR INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS 83
TABLE 8 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
7.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS 84
7.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost the adoption of these solutions 84
TABLE 9 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS 85
TABLE 10 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 85
7.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS 86
7.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market growth 86
TABLE 11 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS 87
TABLE 12 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87
7.2.4 HEALTHCARE INFORMATION EXCHANGE INTEROPERABILITY SOLUTIONS 88
7.2.4.1 Large investments by the federal government to drive the adoption of these solutions 88
TABLE 13 HEALTHCARE INFORMATION EXCHANGE INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS 88
TABLE 14 HEALTHCARE INFORMATION EXCHANGE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 89
7.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS 89
7.2.5.1 Advancing software technology and the rising demand for expanded care delivery are driving the growth of this segment 89
TABLE 15 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY MAJOR PLAYERS 90
TABLE 16 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 90
7.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS 91
TABLE 17 PRACTICE MANAGEMENT AND MEDICAL BILLING SOFTWARE SOLUTIONS OFFERED BY MAJOR PLAYERS 91
TABLE 18 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 92

7.3 SERVICES 92
TABLE 19 SERVICES OFFERED BY MAJOR PLAYERS 93
TABLE 20 HEALTHCARE INTEROPERABILITY SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 94
8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL 95
8.1 INTRODUCTION 96
TABLE 21 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 96
8.2 FOUNDATIONAL INTEROPERABILITY 96
8.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO DRIVE MARKET GROWTH 96
TABLE 22 FOUNDATIONAL INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
8.3 STRUCTURAL INTEROPERABILITY 97
8.3.1 STRUCTURAL INTEROPERABILITY ENSURES INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT THE DATA FIELD LEVEL 97
TABLE 23 STRUCTURAL INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 98
8.4 SEMANTIC INTEROPERABILITY 99
8.4.1 SEMANTIC INTEROPERABILITY SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 99
TABLE 24 SEMANTIC INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100
9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER 101
9.1 INTRODUCTION 102
TABLE 25 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 102
9.2 HEALTHCARE PROVIDERS 102
TABLE 26 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 103
TABLE 27 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019–2026 (USD MILLION) 104
9.2.1 HOSPITALS & CLINICS 104
9.2.1.1 Increasing patient volume and the rising need to reduce errors in data management to drive market growth 104
TABLE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 105
9.2.2 LONG-TERM CARE CENTERS 106
9.2.2.1 Increasing number of long-term care centers and the need to maintain compliance with medical reforms to drive market growth 106
TABLE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR LONG-TERM CARE CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 106
9.2.3 DIAGNOSTIC & IMAGING CENTERS 107
9.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market growth 107
TABLE 30 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 107
9.2.4 OTHER HEALTHCARE PROVIDERS 108
TABLE 31 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2019–2026 (USD MILLION) 109
9.3 HEALTHCARE PAYERS 109
9.3.1 PAYER INTEROPERABILITY HELPS TO DECREASE EMERGENCY DEPARTMENT & HOSPITAL STAYS AND REPEAT TESTS & PROCEDURES 109
TABLE 32 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2019–2026 (USD MILLION) 110
9.4 PHARMACIES 110
9.4.1 PHARMACIES USE HIE SOLUTIONS TO PROVIDE INDIVIDUALIZED CARE AND SUPPORT TO PATIENTS 110
TABLE 33 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR PHARMACIES,
BY COUNTRY/REGION, 2019–2026 (USD MILLION) 111
10 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION 112
10.1 INTRODUCTION 113
FIGURE 24 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 113
TABLE 34 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION,
2019–2026 (USD MILLION) 114
TABLE 35 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114
10.2 NORTH AMERICA 115
FIGURE 25 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT 116
TABLE 36 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 116
TABLE 37 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 38 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 39 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 118
TABLE 40 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 118
TABLE 41 NORTH AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 118
10.2.1 US 119
10.2.1.1 Growing need to curtail soaring healthcare costs to drive market growth in the US 119
TABLE 42 US: KEY MACROINDICATORS 120
TABLE 43 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 44 US: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 45 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 121
TABLE 46 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 122
TABLE 47 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 122
10.2.2 CANADA 122
10.2.2.1 Healthcare digitization to support the adoption of healthcare interoperability solutions in Canada 122
TABLE 48 CANADA: KEY MACROINDICATORS 123
TABLE 49 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 50 CANADA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 51 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 124
TABLE 52 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 125
TABLE 53 CANADA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 125
10.3 EUROPE 125
FIGURE 26 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SNAPSHOT 127
TABLE 54 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 128
TABLE 55 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 56 EUROPE: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 57 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 129
TABLE 58 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 130
TABLE 59 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 130
10.3.1 GERMANY 130
10.3.1.1 Government initiatives to modernize the healthcare system and increasing healthcare expenditure to drive the market growth in Germany 130
TABLE 60 GERMANY: KEY MACROINDICATORS 131
TABLE 61 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 62 GERMANY: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 63 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 133
TABLE 64 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 133
TABLE 65 GERMANY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 133
10.3.2 UK 134
10.3.2.1 Government initiatives to drive the demand for healthcare interoperability solutions in the UK 134
TABLE 66 UK: KEY MACROINDICATORS 134
TABLE 67 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 68 UK: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 69 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 136
TABLE 70 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 136
TABLE 71 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 136
10.3.3 FRANCE 137
10.3.3.1 Government measures to curtail healthcare expenditures to promote the adoption of healthcare interoperability solutions in France 137
TABLE 72 FRANCE: KEY MACROINDICATORS 137
TABLE 73 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 74 FRANCE: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 75 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 139
TABLE 76 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 139
TABLE 77 FRANCE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 139
10.3.4 ITALY 140
10.3.4.1 Government initiatives are driving the healthcare interoperability solutions market in Italy 140
TABLE 78 ITALY: KEY MACROINDICATORS 140
TABLE 79 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 80 ITALY: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 81 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 142
TABLE 82 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 142
TABLE 83 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 142
10.3.5 NETHERLANDS 143
10.3.5.1 Robust healthcare infrastructure and eHealth initiatives are expected to drive the market in the Netherlands 143
TABLE 84 NETHERLANDS: KEY MACROINDICATORS 143
TABLE 85 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 86 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 87 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 145
TABLE 88 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 145
TABLE 89 NETHERLANDS: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 145
10.3.6 REST OF EUROPE 146
TABLE 90 ROE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 91 ROE: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 92 ROE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 147
TABLE 93 ROE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 148
TABLE 94 ROE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 148
10.4 ASIA PACIFIC 148
TABLE 95 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 96 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 97 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 150
TABLE 98 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 151
TABLE 99 ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 151
10.4.1 JAPAN 151
10.4.1.1 Japan is the largest healthcare interoperability market in APAC 151
TABLE 100 JAPAN: KEY MACROINDICATORS 152
TABLE 101 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 102 JAPAN: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 103 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 153
TABLE 104 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 154
TABLE 105 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 154
10.4.2 AUSTRALIA 154
10.4.2.1 Growing government initiatives to drive market growth in Australia 154
TABLE 106 AUSTRALIA: KEY MACROINDICATORS 155
TABLE 107 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 108 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 109 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 156
TABLE 110 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 157
TABLE 111 AUSTRALIA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 157
10.4.3 REST OF ASIA PACIFIC 157
TABLE 112 ROAPAC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 113 ROAPAC: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 114 ROAPAC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 159
TABLE 115 ROAPAC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 160
TABLE 116 ROAPAC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 160
10.5 LATIN AMERICA 160
10.5.1 BRAZIL, ARGENTINA, AND MEXICO ARE SOME OF THE EMERGING HEALTHCARE MARKETS IN LATIN AMERICA 160
TABLE 117 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 118 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 119 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 162
TABLE 120 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 163
TABLE 121 LATIN AMERICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 163
10.6 MIDDLE EAST & AFRICA 163
10.6.1 UAE IS EXPECTED TO OFFER GROWTH OPPORTUNITIES FOR THE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET IN THE REGION 163
TABLE 122 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 123 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 124 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL, 2019–2026 (USD MILLION) 165
TABLE 125 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 166
TABLE 126 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2019–2026 (USD MILLION) 166
11 COMPETITIVE LANDSCAPE 167
11.1 OVERVIEW 167
FIGURE 27 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM JANUARY 2018 TO NOVEMBER 2021 168
11.2 MARKET SHARE ANALYSIS 169
11.2.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 169
TABLE 127 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2020 169
11.3 COMPETITIVE LEADERSHIP MAPPING 170
11.3.1 STARS 170
11.3.2 EMERGING LEADERS 170
11.3.3 PERVASIVE PLAYERS 170
11.3.4 PARTICIPANTS 171
FIGURE 28 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 171
11.4 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS 172
11.4.1 PROGRESSIVE COMPANIES 172
11.4.2 DYNAMIC COMPANIES 172
11.4.3 STARTING BLOCKS 172
11.4.4 RESPONSIVE COMPANIES 172
FIGURE 29 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020) 173
11.5 COMPETITIVE SCENARIO 174
11.5.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 174
TABLE 128 PRODUCT/SERVICE LAUNCHES & APPROVALS, 2018–2021 174
11.5.2 DEALS 175
TABLE 129 DEALS (2018–2021) 175
11.6 COMPETITIVE BENCHMARKING 176
FIGURE 30 FOOTPRINT OF COMPANIES IN THE HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 176
TABLE 130 PRODUCT FOOTPRINT OF COMPANIES (20 COMPANIES) 177
TABLE 131 REGIONAL FOOTPRINT OF COMPANIES (20 COMPANIES) 178
12 COMPANY PROFILES 179
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS 179
12.1.1 CERNER CORPORATION 179
TABLE 132 CERNER CORPORATION: BUSINESS OVERVIEW 179
FIGURE 31 CERNER CORPORATION: COMPANY SNAPSHOT (2020) 180
12.1.2 EPIC SYSTEMS CORPORATION 183
TABLE 133 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW 183
12.1.3 INFOR, INC. 185
TABLE 134 INFOR, INC.: BUSINESS OVERVIEW 185
FIGURE 32 INFOR, INC.: COMPANY SNAPSHOT (2019) 186
12.1.4 INTERSYSTEMS CORPORATION 188
TABLE 135 INTERSYSTEMS CORPORATION: BUSINESS OVERVIEW 188
12.1.5 KONINKLIJKE PHILIPS NV 192
TABLE 136 KONINKLIJKE PHILIPS NV: BUSINESS OVERVIEW 192
FIGURE 33 KONINKLIJKE PHILIPS NV: COMPANY SNAPSHOT (2020) 193
12.1.6 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 195
TABLE 137 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: BUSINESS OVERVIEW 195
FIGURE 34 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2020) 196
12.1.7 COGNIZANT 199
TABLE 138 COGNIZANT: BUSINESS OVERVIEW 199
FIGURE 35 COGNIZANT: COMPANY SNAPSHOT (2020) 200
12.1.8 CHANGE HEALTHCARE 202
TABLE 139 CHANGE HEALTHCARE: BUSINESS OVERVIEW 202
FIGURE 36 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2020) 203
12.1.9 NEXTGEN HEALTHCARE, INC. 205
TABLE 140 NEXTGEN HEALTHCARE, INC.: BUSINESS OVERVIEW 205
FIGURE 37 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020) 205
12.1.10 IBM WATSON HEALTH 207
TABLE 141 IBM WATSON HEALTH: BUSINESS OVERVIEW 207
FIGURE 38 IBM CORPORATION: COMPANY SNAPSHOT (2020) 208
12.1.11 MEDICAL INFORMATION TECHNOLOGY, INC. 209
TABLE 142 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW 209
FIGURE 39 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019) 210
12.1.12 LYNIATE 211
TABLE 143 LYNIATE: BUSINESS OVERVIEW 211
12.1.13 OSP LABS 213
TABLE 144 OSP LABS: BUSINESS OVERVIEW 213
12.1.14 ORION HEALTH GROUP LIMITED 214
TABLE 145 ORION HEALTH GROUP LIMITED: BUSINESS OVERVIEW 214
FIGURE 40 ORION HEALTH GROUP LIMITED: COMPANY SNAPSHOT (2020) 215
12.1.15 ONYX TECHNOLOGY LLC 216
TABLE 146 ONYX TECHNOLOGY LLC: BUSINESS OVERVIEW 216
12.2 OTHER PLAYERS 217
12.2.1 VISOLVE INC. 217
TABLE 147 VISOLVE INC.: BUSINESS OVERVIEW 217
12.2.2 JITTERBIT 218
TABLE 148 JITTERBIT: BUSINESS OVERVIEW 218
12.2.3 INTERFACEWARE INC. 219
TABLE 149 INTERFACEWARE INC.: BUSINESS OVERVIEW 219
12.2.4 VIRTUSA CORP. 220
TABLE 150 VIRTUSA CORP.: BUSINESS OVERVIEW 220
FIGURE 41 VIRTUSA CORPORATION: COMPANY SNAPSHOT (2020) 220
12.2.5 SUMMIT HEALTHCARE SERVICES, INC. 222
TABLE 151 SUMMIT HEALTHCARE SERVICES, INC.: BUSINESS OVERVIEW 222
12.2.6 MPHRX INC. 223
12.2.7 WIPRO LTD. 223
12.2.8 EMIDS TECHNOLOGIES INC. 224
12.2.9 NALASHAA HEALTHCARE 224
12.2.10 DEEVITA LLC 225
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 226
13.1 INSIGHTS FROM INDUSTRY EXPERTS 226
13.2 DISCUSSION GUIDE 227
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 231
13.4 AVAILABLE CUSTOMIZATIONS 233
13.5 RELATED REPORTS 233
13.6 AUTHOR DETAILS 234



★調査レポート[世界の医療用相互運用性ソリューション市場(~2026年):種類別(EHR相互運用性、医療情報交換、企業)、相互運用性レベル別(基礎的、構造的、意味論的)、エンドユーザー別(病院、薬局、クリニック、支払者)] (コード:HIT6989)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医療用相互運用性ソリューション市場(~2026年):種類別(EHR相互運用性、医療情報交換、企業)、相互運用性レベル別(基礎的、構造的、意味論的)、エンドユーザー別(病院、薬局、クリニック、支払者)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆